1. Brain waves found in sleep shown to protect against epileptic activity

    By PharmaTimes The neurological condition affects around 50 million people worldwide Researchers from University College London (UCL) have revealed that slow brain waves that occur during sleep could protect against increased brain excitability in patients living with epilepsy. In a
  2. NIHR launches phase two of its Shape the Future campaign

    By PharmaTimes The campaign was first launched to coincide with the 75th anniversary of the NHS The National Institute for Health and Care Research (NIHR) has announced the launch of its NHS 75: Shape the Future campaign to shape future healthcare. As part of its second phase, the N
  3. NIHR awards £1.5m to fund 13 work and health research projects

    By PharmaTimes The funding will allow several projects to support the health of working people The National Institute for Health and Care Research has awarded £1.5m in funding to 13 development award projects as part of its Work and Health Research Programme. The funding is the firs
  4. Awakn Life Sciences On Track With Phase 3 Trial To Research Substance Use Disorder

    By The Dales Report On this new Psychedelics Exclusive podcast, TDR Founder Shadd Dales interviews Awakn Life Sciences Corp. (OTC: AWKNF ) CEO Anthony Tennyson, as his company moves closer towards a Phase III clinical trial exploring the use of ketamine-assisted therapy to treat se